Validation of Texture Changing Coatings for Use in At-Home Rapid Tests
Launched by UNIVERSITY OF DELAWARE · Aug 1, 2024
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way for people with low vision or blindness to take at-home tests, which is especially important for conditions like COVID-19. Instead of relying on visual results, this test will use special coatings that change texture, allowing individuals to feel the results through touch. This innovation aims to provide greater independence and privacy for those with visual impairments, as it does not require any internet connection or assistance from others.
To participate in this trial, individuals should have been blind or visually impaired for more than 10 years and regularly use tools that help them feel their surroundings, like tactile aids. They should also have a basic understanding of math, similar to what is learned in high school geometry. However, people with certain conditions that affect their hand use, such as amputations, cannot participate. While the trial is not yet recruiting participants, it holds promise for making important health tests more accessible.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Visual Impairment: Participants should be blind or visually impaired for greater than 10 years, either congenitally or acquired.
- • Tactile Aid Usage: Participants must use tactile aids regularly.
- • Mathematical Knowledge: Participants should have a basic understanding of mathematical plots, equivalent to at least high school geometry.
- Exclusion Criteria:
- • Limb Conditions: Participants with amputations or outer extremity conditions affecting hand use will be excluded.
About University Of Delaware
The University of Delaware, a renowned research institution, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its expertise in various fields, including health sciences, engineering, and behavioral health, to conduct rigorous and ethical research. The university's commitment to scientific excellence and community engagement ensures that its clinical trials not only contribute to groundbreaking discoveries but also prioritize participant safety and well-being. Through its state-of-the-art facilities and a team of experienced researchers, the University of Delaware is positioned to make significant contributions to the field of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Newark, Delaware, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported